Malaria Vaccines: Progress to Date Danielle I. StanisicMichael F. Good Review Article Open access 20 September 2023 Pages: 737 - 756
Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies Parul BerrySahil Khanna Review Article 26 July 2023 Pages: 757 - 773
Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer Khaled SanberSamuel RosnerKristen A. Marrone Review Article 21 August 2023 Pages: 775 - 791
Enzyme Engineering Strategies for the Bioenhancement of l-Asparaginase Used as a Biopharmaceutical Javiera MirandaNicolás LefinMauricio Zamorano Review Article 12 September 2023 Pages: 793 - 811
Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data Ezgi Deniz BatuSeher SenerSeza Ozen Review Article 29 June 2023 Pages: 813 - 828
Patients’ Perceptions of Biosimilars: A Systematic Review Qiyou WuZhitao WangJing Sun Systematic Review 07 September 2023 Pages: 829 - 841
Acute Kidney Injury from Intravitreal Anti-vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Controlled Trials Yu-Chien TsaoTing-Ying ChenEdward Chia-Cheng Lai Systematic Review 07 September 2023 Pages: 843 - 854
Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars? Nadine Kirsch-StefanElena GuillenElena Wolff-Holz Original Research Article Open access 13 October 2023 Pages: 855 - 871
The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune‐Mediated Inflammatory Disease Ulf Müller-LadnerAxel DignassJanet Addison Original Research Article Open access 26 August 2023 Pages: 873 - 889
Real-World Clinical Outcomes of Bevacizumab-awwb Biosimilar versus Bevacizumab Reference Product in Patients with Metastatic Colorectal Cancer Catherine PhamFang NiuRita L. Hui Original Research Article 25 September 2023 Pages: 891 - 899
